PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 15 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Oral treatment with Aralox (containing Aralia mandshurica and Engelhardtia chrysolepis) led to decreased total body weight, fat weight, plasma triglyceride content, and reduced perilipin content in adipocytes, while stimulating hormone-sensitive lipase activity [PMID:17073156].
Chronic administration of Aralia mandshurica extract increased cardiac resistance to arrhythmogenic actions [PMID:18318196] and reduced the incidence of ischemic and reperfusion ventricular arrhythmias [PMID:19529855].
Chronic treatment elevated the ventricular fibrillation threshold in rats [PMID:19529855].
Saponin extracts decreased plasma glucose levels in resting rats [PMID:6379247].
Evidence summary
PubMed sources
- 1.PMID: 37916310 (2023) — Research progress in pharmacological effects of Aralia elata. · Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
- 2.PMID: 18318196 (2007) — [Cardioprotective and antiarrhythmic properties of preparations from Leuzea carthamoides, Aralia mandshurica, and Eleutherococcus senticosus]. · Eksperimental'naia i klinicheskaia farmakologiia
- 3.PMID: 6379247 (1984) — The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. · Japanese journal of pharmacology
- 4.PMID: 19505042 (2009) — [Phytoadaptogens-induced phenomenon similar to ischemic preconditioning]. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova
- 5.PMID: 19529855 (2009)